This is the authors' abstract. We don't add key points for this paper.
Introduction of the romA gene cloned from Enterobacter cloacae into Escherichia coli K-12 resulted in almost complete inhibition of OmpF expression and a concomitant increase in resistance to quinolones, beta-lactams, chloramphenicol, and tetracyclines. In addition, the romA gene reduced the susceptibility to these multiple drugs even in the OmpF porin-deficient mutants of E. coli K-12. Results indicate the presence of romA-sensitive penetration pathway(s) for these multiple drugs other than the OmpF porin in E. coli.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Komatsu et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: